AMY STEVENS: Open Payments
NPI 1104165083 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 29 payments from 7 companies in 2025. Trend: 2023 $757 · 2024 $1,071 · 2025 $695
Food & beverage: $611Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $493 |
| Janssen Biotech, Inc. | 2 | $100 |
| Janssen Scientific Affairs, LLC | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: CREON, RINVOQ, LINZESS, TREMFYA, SKYRIZI, ENTYVIO, OCALIVA, OMVOH.
Industry payments across TX — which companies pay providers there.
